Status:
COMPLETED
Assessing Social Determinants of Health to Increase Cancer Screening
Lead Sponsor:
Hackensack Meridian Health
Collaborating Sponsors:
Becton, Dickinson and Company
Conditions:
Lung Cancer
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
A multilevel lung screening intervention that pairs Social Determinants of Health (SDoH) screening and referral with a tailored health communication and decision support tool for lung screening has th...
Detailed Description
The study will be a pilot randomized controlled trial (RCT) to compare primary (LCS uptake) and secondary outcomes (intent to screen, literacy, mistrust, stigma, fatalism, health beliefs) among LCS-el...
Eligibility Criteria
Inclusion
- Aged 50 years to 80 years
- Currently smoke or quit smoking within the past 15 years
- 20 pack-year smoking history
- Has never had lung cancer screening
- Able to provide informed consent
- Able to speak and understand English
Exclusion
- Diagnosed with lung cancer
- Has a history of having a lung cancer screening scan
- Unable to speak and understand English
Key Trial Info
Start Date :
September 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2025
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT06052449
Start Date
September 30 2023
End Date
August 19 2025
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack Meridian Health - Center for Discovery and Innovation
Nutley, New Jersey, United States, 07110